Clinical Trials Logo

Healthy Elderly Volunteers clinical trials

View clinical trials related to Healthy Elderly Volunteers.

Filter by:
  • None
  • Page 1

NCT ID: NCT03818802 Recruiting - Clinical trials for Healthy Elderly Volunteers

Effects of Vitamin B3 Derivative Nicotinamide Riboside (NR) in Bone, Skeletal Muscle and Metabolic Functions in Aging

Start date: September 16, 2019
Phase: N/A
Study type: Interventional

Researchers are trying to determine if the vitamin B3 derivative Nicotinamide Riboside (NR) has any effects in bone, skeletal muscle, and metabolic functions and structure in aging.

NCT ID: NCT01795339 Completed - Clinical trials for Healthy Elderly Volunteers

A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients

Start date: March 2013
Phase: Phase 1
Study type: Interventional

This is a two-part multiple dose study in healthy male and female (of non-child bearing potential) elderly volunteers, and in Alzheimer's disease patients, to assess the safety, effects on the body, and blood, CSF, and urine drug levels of AZD3293. AZD3293 is being developed for the treatment of Alzheimer's Disease

NCT ID: NCT01739647 Completed - Clinical trials for Healthy Elderly Volunteers

A Single Dose Study to Assess the Safety, Effects, and Blood and Urine Drug Levels of AZD3293 in Healthy Subjects

Start date: December 2012
Phase: Phase 1
Study type: Interventional

This is a single dose study in healthy male and female (of non-child bearing potential) volunteers, to assess the safety, effects on the body, and blood and urine drug levels of AZD3293. AZD3293 is being developed for the treatment of Alzheimer's Disease

NCT ID: NCT01215552 Terminated - Clinical trials for Healthy Elderly Volunteers

Study of the Inhibition of [11C]R-rolipram Binding to Brain Phosphodiesterase - 4 (PDE-4) by HT-0712

Start date: September 2010
Phase: Phase 1
Study type: Interventional

This Positron Emission Tomography (PET) imaging study is designed to explore the relationship between HT-0712 dose level and inhibition of brain phosphodiesterase-4 activity, in order to optimize the dosage regimens utilized in subsequent trials.

NCT ID: NCT00903253 Completed - Clinical trials for Healthy Elderly Volunteers

A Double-Blind, Placebo Controlled, Single, Escalating Dose Study to Evaluate the Preliminary Pharmacokinetics, Safety and Tolerability of LNK-754 in Healthy Elderly Volunteers

Start date: May 2009
Phase: Phase 1
Study type: Interventional

The objective of this study is to evaluate the single-dose plasma pharmacokinetics of LNK-754 as well as safety and tolerability in normal healthy male and female elderly volunteers